November 16, 2025 - 21:25

Veritas Capital has announced its decision to acquire MetroStar Systems, a prominent provider of digital transformation and artificial intelligence solutions based in Reston, Virginia. MetroStar specializes in serving U.S. Defense and National Security agencies, making this acquisition a significant move within the national security technology landscape.
The deal, which is being facilitated through affiliates of The Veritas Capital Vantage Fund, is expected to bolster Veritas' standing in the realm of mission-critical government technology. This acquisition not only enhances Veritas' portfolio but also positions MetroStar for accelerated growth and increased capacity for innovation.
As the demand for advanced technological solutions in defense and national security continues to rise, this strategic acquisition underscores the commitment of both companies to deliver cutting-edge services and support to government entities. The collaboration is anticipated to yield substantial benefits, enhancing operational efficiency and effectiveness in critical areas of national security.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...